Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study
NCT01153464 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2017-03-30
Summary
This protocol (a supplement to 805466) is to test whether our telephone continuing care model can be implemented successfully by "real world" publicly funded programs. Participants will be recruited from Philadelphia's Department of Behavioral Health - run drug programs. The investigators will train city telephone care managers to deliver our telephone continuing care intervention to patients in this program. The investigators will randomize 200 to receive this intervention or usual care and follow them for 12 months.
Conditions
- Cocaine Dependence
Interventions
- BEHAVIORAL
-
Recovery Support Counseling
Telephone based recovery support provided by paraprofessionals at the City of Philadelphia's Behavioral Health Department. Calls are once weekly for 8 weeks, then step down to every other week for the remainder of the year of study participation. Call frequency can be increased as a result of a rise in risk factor/protective factor ratio.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2011-09-30
- Completion
- 2011-09-30
Countries
- United States
Study Locations
More Related Trials
-
Nefazodone in the Treatment of Cocaine Dependence and Depression - 4
NCT00015210 ·Status: COMPLETED ·Phase: PHASE2
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2
-
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
NCT00000276 ·Status: TERMINATED ·Phase: PHASE1
-
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208 ·Status: COMPLETED ·Phase: NA
-
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
NCT03344419 ·Status: SUSPENDED ·Phase: PHASE3
-
Extending Long-term Outcomes Through an Adaptive Aftercare Intervention
NCT02143063 ·Status: COMPLETED ·Phase: NA
-
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
NCT00218075 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Costs of Enhanced Cocaine Treatments
NCT00167258 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Use Reduction and Health
NCT03224546 ·Status: COMPLETED ·Phase: NA
-
Imaging the Neurobiology of a Behavioral Treatment for Cocaine Dependence
NCT00376558 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate Whether AFQ056 Reduces Cocaine Use in Patients Diagnosed With Cocaine Use Disorder (CUD)
NCT03242928 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
NCT02018263 ·Status: COMPLETED ·Phase: PHASE1
-
Cocaine Use Disorder and Cortical Dopamine
NCT03349606 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence
NCT02534454 ·Status: COMPLETED ·Phase: NA
-
Cocaine Withdrawal and Pharmacotherapy Response
NCT00566969 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects
NCT00808119 ·Status: COMPLETED ·Phase: PHASE1
-
Disulfiram for Cocaine Abuse in Buprenorphine Treatment
NCT00913484 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Abuse and ADHD - 10
NCT00000275 ·Status: COMPLETED ·Phase: PHASE2
-
Reinforcing Effects of Cocaine During Phendimetrazine Maintenance
NCT02522325 ·Status: COMPLETED ·Phase: PHASE1
-
Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence
NCT00527683 ·Status: COMPLETED ·Phase: PHASE2
-
Developing Computer Based Treatments for Addiction
NCT00586534 ·Status: COMPLETED ·Phase: NA
-
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
NCT01739192 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3
NCT00015054 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder
NCT05529927 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cocaethylene as a Treatment for Cocaine Dependence - 1
NCT00124696 ·Status: COMPLETED ·Phase: PHASE1